The developed chitosan-coated Eudragit® S100 nanoparticle system represents a promising platform for sustained, colon-targeted oral delivery of HSP and other poorly bioavailable bioactive compounds.
Abstract
Hesperetin (HSP), a naturally occurring citrus flavanone with diverse antioxidant, anti-inflammatory, and pharmacological activities, has attracted considerable attention as a promising candidate for oral therapeutic delivery. However, its pharmaceutical applicability remains limited due to poor aqueous solubility, rapid metabolism, limited intestinal permeability, and low oral bioavailability. In the present study, chitosan-coated Eudragit® S100 nanoparticles were developed and optimized for colon-targeted delivery of HSP using a hybrid ionic gelation–solvent evaporation technique. Formulation optimization was performed using a 3² factorial response surface design by varying the Eudragit® S100:Chitosan ratio and Poloxamer-188 concentration. The developed nanoparticles were characterized for particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, morphology, crystallinity, in vitro drug release, and Ex vivo intestinal permeation behavior. The optimized formulation (F4) exhibited nanosized particles (195.4 ± 6.2 nm), a narrow size distribution, a favorable zeta potential (− 31.0 ± 2.0 mV), and a high entrapment efficiency (86.7 ± 2.6%). FTIR, DSC, and XRD analyses confirmed successful incorporation and partial amorphization of HSP within the polymeric matrix without significant incompatibility, while SEM analysis demonstrated spherical nanoparticles with smooth surface morphology. In vitro release studies revealed minimal drug release under gastric conditions, followed by sustained and controlled release at colonic pH over 24 h. Drug release kinetics predominantly followed the Korsmeyer–Peppas model with anomalous non-Fickian diffusion behavior. Ex vivo permeation studies further demonstrated enhanced intestinal permeation and prolonged mucosal retention of the optimized nanoparticles. However, the study was limited to in vitro and ex vivo evaluations, warranting further in vivo validation. The developed chitosan-coated Eudragit® S100 nanoparticle system, therefore, represents a promising platform for sustained, colon-targeted oral delivery of HSP and other poorly bioavailable bioactive compounds.
This study showed that mucoadhesive polymeric nanoparticles of vonoprazan significantly enhanced solubility, pH-dependent release, and improved mucoadhesion, making it a promising approach to improve the oral bioavailability of drugs with poor water solubility.
S. Sajjad, U. Tulain, M. Asim et al.· International Journal of Nan...· 0 citations
Lamotrigine-loaded chitosan-sodium alginate polymeric nanoparticle system optimized by BoxBehnken Design demonstrated improved release control, enhanced pharmacokinetic parameters, and superior anticonvulsant activity in vivo, supporting their potential as a sustained-release system for epilepsy management.
D. R, J. B., K. M et al.· Drug Delivery Letters· 0 citations
The developed nanoliposomal system offers significant clinical advantages including potential for enhanced tumor targeting, reduced dosing frequency, and minimized systemic toxicity, pending in vivo validation, and improved therapeutic outcomes.
Mayur R. Nikam, D. Sonawane, A. Pawar· BioNanoScience· 0 citations
Evidence from recent studies demonstrates that MSNs significantly improve drug loading efficiency, enhance solubility and bioavailability, and reduce off-target toxicity, Consequently, MSNs represent a highly versatile and modifiable platform with considerable potential for addressing the limitations of conventional dr...
Ahmad Ainurofiq, Y. Ramadhana, Salma Aqilah Rachmadani et al.· Recent Advances in Drug Deli...· 0 citations
A pH-responsive, dual-layered curcumin-chitosan nanoemulsion system using the phase inversion temperature method coupled with probe ultrasonication is developed, highlighting nCCURs as a high-performance oral delivery platform for hydrophobic nutraceuticals.
Quang-Hieu Tran, Xuan-Dung Pham, T. Pham et al.· Royal Society Open Science· 0 citations
The therapeutic application of nanoemulgels in dermatological, anti-inflammatory, antimicrobial, and cosmetic applications is exemplified to clarify improvements in therapeutic efficacy, decreased systemic toxicity, and increased patient acceptability.
M. Zafar, Prevesh Kumar, Diksha et al.· Recent Advances in Drug Deli...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.